Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines

Descripción del Articulo

Triple-negative breast tumours (TNBTs) make up 15-20% of all breast tumours. There is no treatment for them, and the role that cancer stem cells (CSCs) have in carcinogenesis is still unclear, so finding markers and therapeutic targets in CSC exosomes requires these cells to exist as a homogeneous c...

Descripción completa

Detalles Bibliográficos
Autor: Enciso-Benavides, J.
Formato: artículo
Fecha de Publicación:2021
Institución:Instituto Nacional de Enfermedades Neoplásicas
Repositorio:INEN-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.inen.sld.pe:20.500.14703/507
Enlace del recurso:https://hdl.handle.net/20.500.14703/507
Nivel de acceso:acceso abierto
Materia:CD44high/CD24low phenotype cells
Cancer stem cells
Magnetic immunoselection
Triple-negative breast tumors.
https://purl.org/pe-repo/ocde/ford#3.02.21
id INEN_97e86bce15eb0074cd1592d77bfc3582
oai_identifier_str oai:repositorio.inen.sld.pe:20.500.14703/507
network_acronym_str INEN
network_name_str INEN-Institucional
repository_id_str .
spelling PublicationEnciso-Benavides, J.2026-04-28T14:20:37Z202110.1016/j.heliyon.2021.e07273https://hdl.handle.net/20.500.14703/507Triple-negative breast tumours (TNBTs) make up 15-20% of all breast tumours. There is no treatment for them, and the role that cancer stem cells (CSCs) have in carcinogenesis is still unclear, so finding markers and therapeutic targets in CSC exosomes requires these cells to exist as a homogeneous cell population. The objective of this work was to determine differences in ultrastructural morphology, proliferative capacity, and mouse-xenotransplantation characteristics of the MDA-MB-231 and MDA-MB-436 TNBT cell lines with the CD44 high /CD24 low phenotype in order to study their exosomes. The results show that the CD44 high /CD24 low MBA-MB-231 cells had a population doubling time of 41.56 h, compared to 44.79 h in the MDA-MB-436 cell line. After magnetic immunoseparation, 18.75% and 14.56% of the stem cell population of the MDA-MB-231 and MDA-MB-436 cell lines, respectively, were of the CD44 high /CD24 low phenotype, which were expanded to reach purities of 80.4% and 87.6%. The same expanded lineage in both cell lines was shown to possess the pluripotency markers Nanog and Oct4. Under a scanning electron microscope, the CD44 high /CD24 low lineage of the MBA-MD-231 cell line formed groups of more interconnected cells than this lineage of the MBA-MD-436 line. A total of 16% of the mice inoculated with the CD44 high /CD24 low lineage of either cell line presented tumours of the breast, lung, and submandibular ganglia, in whose tissues variable numbers of inoculated cells were found 30 days post-inoculation. By magnetic immunoselection, it was possible to isolate in similar quantities and characterize, expand, and xenotransplant the CD44 high /CD24 low lineage of the MDA-MB-231 and MDA-MB-436 cell lines. The former cell line has greater proliferative capacity, the two lines differ under scanning electron microscopy in how they intercommunicate, and both cell lines induce new tumours in mice and persist at least 30 days post-inoculation in the transplanted animal so their exosomes would also be different.application/pdfengHeliyonUKElsevier Ltdinfo:eu-repo/semantics/openAccesshttps//creativecomons.org/licenses/by/4.0/CD44high/CD24low phenotype cellsCancer stem cellsMagnetic immunoselectionTriple-negative breast tumors.https://purl.org/pe-repo/ocde/ford#3.02.21Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell linesinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INEN20.500.14703/507oai:repositorio.inen.sld.pe:20.500.14703/5072026-04-28T14:20:37.637921Zhttps//creativecomons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessmetadata.onlyhttps://repositorio.inen.sld.peRepositorio del Instituto Nacional de Enfermedades Neoplásicasrepositorio@inen.sld.pe
dc.title.none.fl_str_mv Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
title Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
spellingShingle Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
Enciso-Benavides, J.
CD44high/CD24low phenotype cells
Cancer stem cells
Magnetic immunoselection
Triple-negative breast tumors.
https://purl.org/pe-repo/ocde/ford#3.02.21
title_short Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
title_full Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
title_fullStr Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
title_full_unstemmed Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
title_sort Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
author Enciso-Benavides, J.
author_facet Enciso-Benavides, J.
author_role author
dc.contributor.author.fl_str_mv Enciso-Benavides, J.
dc.subject.none.fl_str_mv CD44high/CD24low phenotype cells
Cancer stem cells
Magnetic immunoselection
Triple-negative breast tumors.
topic CD44high/CD24low phenotype cells
Cancer stem cells
Magnetic immunoselection
Triple-negative breast tumors.
https://purl.org/pe-repo/ocde/ford#3.02.21
dc.subject.ocde.none.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.02.21
description Triple-negative breast tumours (TNBTs) make up 15-20% of all breast tumours. There is no treatment for them, and the role that cancer stem cells (CSCs) have in carcinogenesis is still unclear, so finding markers and therapeutic targets in CSC exosomes requires these cells to exist as a homogeneous cell population. The objective of this work was to determine differences in ultrastructural morphology, proliferative capacity, and mouse-xenotransplantation characteristics of the MDA-MB-231 and MDA-MB-436 TNBT cell lines with the CD44 high /CD24 low phenotype in order to study their exosomes. The results show that the CD44 high /CD24 low MBA-MB-231 cells had a population doubling time of 41.56 h, compared to 44.79 h in the MDA-MB-436 cell line. After magnetic immunoseparation, 18.75% and 14.56% of the stem cell population of the MDA-MB-231 and MDA-MB-436 cell lines, respectively, were of the CD44 high /CD24 low phenotype, which were expanded to reach purities of 80.4% and 87.6%. The same expanded lineage in both cell lines was shown to possess the pluripotency markers Nanog and Oct4. Under a scanning electron microscope, the CD44 high /CD24 low lineage of the MBA-MD-231 cell line formed groups of more interconnected cells than this lineage of the MBA-MD-436 line. A total of 16% of the mice inoculated with the CD44 high /CD24 low lineage of either cell line presented tumours of the breast, lung, and submandibular ganglia, in whose tissues variable numbers of inoculated cells were found 30 days post-inoculation. By magnetic immunoselection, it was possible to isolate in similar quantities and characterize, expand, and xenotransplant the CD44 high /CD24 low lineage of the MDA-MB-231 and MDA-MB-436 cell lines. The former cell line has greater proliferative capacity, the two lines differ under scanning electron microscopy in how they intercommunicate, and both cell lines induce new tumours in mice and persist at least 30 days post-inoculation in the transplanted animal so their exosomes would also be different.
publishDate 2021
dc.date.accessioned.none.fl_str_mv 2026-04-28T14:20:37Z
dc.date.issued.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.1016/j.heliyon.2021.e07273
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.14703/507
identifier_str_mv 10.1016/j.heliyon.2021.e07273
url https://hdl.handle.net/20.500.14703/507
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Elsevier Ltd
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv https//creativecomons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https//creativecomons.org/licenses/by/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Heliyon
dc.publisher.country.none.fl_str_mv UK
publisher.none.fl_str_mv Heliyon
dc.source.none.fl_str_mv reponame:INEN-Institucional
instname:Instituto Nacional de Enfermedades Neoplásicas
instacron:INEN
instname_str Instituto Nacional de Enfermedades Neoplásicas
instacron_str INEN
institution INEN
reponame_str INEN-Institucional
collection INEN-Institucional
repository.name.fl_str_mv Repositorio del Instituto Nacional de Enfermedades Neoplásicas
repository.mail.fl_str_mv repositorio@inen.sld.pe
_version_ 1865267643840200704
score 13.916713
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).